ValiRx Plc (LON: VAL) shares today surged 30.6% higher after the pharmaceutical company released an update on its total voting rights based on the number of ordinary shares in issue, which are 56,854,039 in total.
The company’s total shares are set to increase on 3rd September once the 250,000 ordinary shares are admitted to trading on the AIM after the company wrote to the London Stock Exchange to have the shares admitted due to the exercise of warrants.
The company had listed over 9 million new ordinary shares on the LSE on 19th August, which had been admitted for trading on the AIM on 24th August.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
ValiRx develops innovative medicines to improve patient outcomes and has several promising projects in the pipeline such as VAL201, VAL301, VAl401 and BC201.
The company also enjoys strong insider ownership, which attests to the management’s confidence in its future prospects, thus, presenting a solid investment case.
ValiRx share price
Source: Tradingview
ValiRx shares today surged 30.6% to trade at 19.40p having rallied from Friday’s closing price of 14.86p.
- Here are our latest trending stories now
- Trade stocks with the highly-rated IG UK
- Find alternative brokers to Hargreaves Lansdown